ArticleMolecular cancer therapeutics2015

Evaluation of the in vitro and in vivo efficacy of the JAK inhibitor AZD1480 against JAK-mutated acute lymphoblastic leukemia.

Santi Suryani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.